Phil Frost
About Phil Frost
Phil Frost - Title and Leadership Positions
Phil Frost is the CEO and Chairman of his current company. He has extensive leadership experience, having served as the Chairman of the Board and Vice Chairman at Teva Pharmaceutical Industries. His leadership roles also include serving as Chairman of the Board of Directors and CEO of IVAX Corporation from 1987 until IVAX was acquired by Teva in January 2006. Additionally, he has held chairman positions at Key Pharmaceuticals and Ladenburg Thalmann Financial Services.
Phil Frost - Board Memberships
Over his career, Phil Frost has been involved with several boards. He has served as a director of Continucare Corporation and Castle Brands, Inc. He actively contributes to the governance of educational and medical institutions such as the University of Miami, where he is a past chairman and current Board of Trustees member. Additionally, he is a Trustee of the Shanghai Institute for Advanced Immunochemical Studies in China, the Miami Jewish Home for the Aged, and the Mount Sinai Medical Center.
Phil Frost - Contributions to Financial and Scientific Organizations
In the realm of scientific and financial organizations, Phil Frost has served as a Governor and Co-Vice-Chairman of the American Stock Exchange. His scientific advisory roles have included being a past Trustee of the Scripps Research Institute and the Board of Regents of The Smithsonian Institution. He was also a member of the Skolkovo Foundation Scientific Advisory Council in Russia. Currently, he serves on the Executive Committee of the Phillip and Patricia Frost Museum of Science.
Phil Frost - Role in Biotechnology
Phil Frost is involved in the biotechnology sector as a director of Cocrystal Pharma, Inc., which is a publicly traded biotechnology company focusing on developing new treatments for viral diseases. This role adds to his credentials in spearheading pharmaceutical and biotech innovations.